Chicago Partners Investment Group’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $163K | Buy |
40,989
+363
| +0.9% | +$1.44K | ﹤0.01% | 1052 |
|
|
2025
Q1 | $127K | Buy |
40,626
+20,067
| +98% | +$62.8K | ﹤0.01% | 892 |
|
|
2024
Q4 | $147K | Hold |
20,559
| – | – | ﹤0.01% | 825 |
|
|
2024
Q3 | $202K | Hold |
20,559
| – | – | 0.01% | 763 |
|
|
2024
Q2 | $184K | Hold |
20,559
| – | – | 0.01% | 719 |
|
|
2024
Q1 | $244K | Hold |
20,559
| – | – | 0.01% | 630 |
|
|
2023
Q4 | $157K | Buy |
20,559
+2,688
| +15% | +$20.6K | 0.01% | 672 |
|
|
2023
Q3 | $61.7K | Buy |
17,871
+5,000
| +39% | +$17.3K | ﹤0.01% | 637 |
|
|
2023
Q2 | $92.4K | Hold |
12,871
| – | – | ﹤0.01% | 660 |
|
|
2023
Q1 | $73.4K | Hold |
12,871
| – | – | ﹤0.01% | 646 |
|
|
2022
Q4 | $106K | Hold |
12,871
| – | – | 0.01% | 618 |
|
|
2022
Q3 | $106K | Buy |
12,871
+2,000
| +18% | +$16.5K | 0.01% | 561 |
|
|
2022
Q2 | $127K | Buy |
+10,871
| New | +$127K | 0.01% | 563 |
|